| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 1988.01 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 1334.23 | 97 |
| GSM780709 | Untreated after 4 days (C3_1) | 1265.78 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 2051.64 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 1429.14 | 97 |
| GSM780721 | Untreated after 4 days (C3_2) | 1302.05 | 97 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1202.31 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1452.18 | 97 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1435.04 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1098.86 | 96 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 1612.25 | 97 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1459.51 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1952.57 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 1455.93 | 97 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 1667.72 | 97 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1846.44 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1493.12 | 97 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 1828.11 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 1815.53 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1435.04 | 97 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1587.83 | 97 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1743.65 | 98 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1518.11 | 97 |